pirinixic acid has been researched along with oxazolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auwerx, J; Elias, PM; Feingold, KR; Fluhr, JW; Fowler, AJ; Kao, J; Man, MQ; Schmuth, M; Schoonjans, K; Sheu, MY | 1 |
| Crumrine, D; Elias, PM; Feingold, KR; Fujiwara, S; Hatano, Y; Katagiri, K | 1 |
2 other study(ies) available for pirinixic acid and oxazolone
| Article | Year |
|---|---|
Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models.
Topics: Adjuvants, Immunologic; Administration, Topical; Animals; Clofibrate; Dermatitis, Allergic Contact; Drug Eruptions; Female; Interleukin-1; Irritants; Linoleic Acid; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Oxazolone; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Tetradecanoylphorbol Acetate; Transcription Factors; Tumor Necrosis Factor-alpha | 2002 |
Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.
Topics: Adjuvants, Immunologic; Animals; Clobetasol; Dermatitis, Atopic; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Epidermis; Female; Glucocorticoids; Haptens; Mice; Mice, Hairless; Naphthols; Oxazolone; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Secondary Prevention; Triazines | 2011 |